Condition: Acute Myeloid Leukemia in Remission · Myelodysplastic Syndromes · Chronic Myeloid Leukemia in Remission · Sponsor: University of Liege
The present project aims at comparing two conditioning regimens (FM-PTCy vs FM-ATG). The hypothesis is that one or the two regimens will lead to a 2-year cGRFS rate improvement from 30% (the cGRFS rate with FM without ATG/PTCy) to 45% (Pick-a-winner phase 2 randomized study).
This description comes directly from the study's public registry record.
Frédéric Baron, MD,Ph · +32 4 366 72 01 · F.Baron@uliege.be
Always discuss trial participation with your own doctor first.
| ZNA Stuivenberg | Antwerp, Belgium | Recruiting |
| AZ Sint Jan Brugge | Bruges, Belgium | Recruiting |
| IJ Bordet | Brussels, Belgium | Recruiting |
| UZ Brussel | Brussels, Belgium | Recruiting |
| UCL St Luc | Brussels, Belgium | Recruiting |
| UZ Gent | Ghent, Belgium | Recruiting |
| UZ Leuven | Leuven, Belgium | Recruiting |
| CHU de Liège | Liège, Belgium | Recruiting |
| AZ Delta Roeselare | Roeselare, Belgium | Recruiting |
| CHU UCL Namur Godinne | Yvoir, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03852407